{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-011375","form_type":"8-K","ticker":"KALA","cik":"0001479419","company_name":"KALA BIO, Inc.","filed_at":"2023-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.996110+00:00","generated_at":"2026-06-13T17:55:40.487658+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Kala shareholders approve equity plan increase, reject name change at annual meeting","bullets":["Approved A&R 2017 Equity Incentive Plan; adds 1.25M shares, extends term to June 2033.","Elected C. Daniel Myers and Howard B. Rosen as Class III directors for three-year terms.","Advisory vote on executive compensation passed (498,054 for, 57,912 against); frequency set every year.","Proposal to rename to 'Kala Bio, Inc.' did not receive required votes; 1.15M for vs 11,194 against."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-011375","json":"https://secwatch.observer/filing/0001558370-23-011375.json","markdown":"https://secwatch.observer/filing/0001558370-23-011375.md","text":"https://secwatch.observer/filing/0001558370-23-011375.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479419/000155837023011375/0001558370-23-011375-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479419/000155837023011375/kala-20230622x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T17:55:40.487658+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"52ce7a983aa955be0654d6248706faee160118db","claim":"KALA BIO, Inc. shareholders approved Election of C. Daniel Myers and Howard B. Rosen as Class III directors.","evidence_excerpt":"The results of the stockholders’ vote with respect to the election of such Class III directors were as follows: ​ Votes For Votes Withheld Broker Non- Votes C. Daniel Myers 544,974 26,177 594,432 Howard B. Rosen 550,334 20,817 594,432","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1479419/000155837023011375/0001558370-23-011375-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"803fbb257ea559de5c7c0a79ec10f9eb78e046f5","claim":"KALA BIO, Inc. shareholders approved Non-binding advisory vote on frequency of future say-on-pay votes.","evidence_excerpt":"were as follows: ​ Every One Year Every Two Years Every Three Years Votes Abstaining Broker Non- Votes 546,761 4,425 17,435 2,530 594,432","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1479419/000155837023011375/0001558370-23-011375-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"8494aca1bf345f1218f8fe76068eab638099eb90","claim":"KALA BIO, Inc. shareholders rejected Amendment to Restated Certificate of Incorporation to change company name to Kala Bio, Inc..","evidence_excerpt":"were as follows: ​ Votes For Votes Against Votes Abstaining Broker Non- Votes 1,151,465 11,194 2,924 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1479419/000155837023011375/0001558370-23-011375-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"failed"}],"fact_type":"shareholder_vote"},{"claim_id":"8bec3bea6e5fc18163e2b0e4204b968a6c104877","claim":"KALA BIO, Inc. shareholders approved Approval of Amended and Restated 2017 Stock Option and Incentive Plan.","evidence_excerpt":"were as follows: ​ Votes For Votes Against Votes Abstaining Broker Non- Votes 495,640 71,992 3,519 594,432","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1479419/000155837023011375/0001558370-23-011375-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"9bc61b6a849eb7bdc4ac7d45dac098abcd224653","claim":"KALA BIO, Inc. shareholders approved Non-binding advisory vote on compensation paid to named executive officers.","evidence_excerpt":"2. The Company’s stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers. The results","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1479419/000155837023011375/0001558370-23-011375-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}